• Spectrum Pharmaceuticals Inc., of Henderson, Nev., reported that its total GAAP consolidated revenue was $267.7 million for the 12-month period ending Dec. 31, 2012, representing a 38.7 percent increase from the $193 million in consolidated revenue recorded in the same period of 2011.